Monte Financial Group, LLC Amgen Inc Transaction History

Monte Financial Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$166.7 - $195.41 $1.78 Million - $2.09 Million	-10,691 Closed	0 $0
Q1 2019 Apr 23, 2019	SELL	$180.87 - $203.88 $740,481 - $834,684	-4,094 Reduced 27.69%	10,691 $2.03 Million
Q4 2018 Jan 31, 2019	BUY	$178.4 - $208.25 $48,524 - $56,644	272 Added 1.87%	14,785 $2.88 Million
Q3 2018 Oct 16, 2018	BUY	$185.29 - $208.89 $82,083 - $92,538	443 Added 3.15%	14,513 $3.01 Million
Q2 2018 Oct 16, 2018	BUY	$166.05 - $186.51 $38,855 - $43,643	234 Added 1.69%	14,070 $2.6 Million
Q1 2018 Oct 16, 2018	BUY	$169.43 - $198.0 $201,113 - $235,026	1,187 Added 9.38%	13,836 $2.36 Million
Q4 2017 Oct 16, 2018	BUY	$168.79 - $188.59 $2.14 Million - $2.39 Million	12,649	12,649 $2.2 Million

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Monte Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Monte Financial Group, LLC with notifications on news.